A study for patients with rheumatoid arthritis who are taking oral methotrexate and have an inadequate response.

  • Patients will receive tocilizumab (Actemra) by injection either once a week or once every 2 weeks along with methotrexate.
  • Once arthritis symptoms improve, methotrexate may be discontinued.
  • The medication, Actemra, will be provided by the study.

Contact Candace LeBlanc, RN at 508-556-5431 or Marcy Kirkpatrick, RN at 508-556-5429 for more information.